Does Rallies show Form 4 insider transactions for COSM?

Yes. Rallies tracks COSM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is COSM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for COSM. It does not provide personalized investment advice.

COSM (Cosmos Holdings Inc. Common Stock) Stock Analysis - Insider Trades

Cosmos Holdings Inc. Common Stock (COSM) is a publicly traded Healthcare sector company. As of May 21, 2026, COSM trades at $0.27 with a market cap of $15.37M and a P/E ratio of -0.45. COSM moved +0.00% today. Year to date, COSM is -46.43%; over the trailing twelve months it is -36.40%. Its 52-week range spans $0.28 to $1.32. Rallies surfaces COSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading COSM stock inside the company?

Recent COSM insider activity includes Siokas Grigorios bought 388.53K, Siokas Grigorios bought 291.26K, Siokas Grigorios bought 90.33K, Siokas Grigorios bought 353.32K, and Siokas Grigorios bought 493.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

COSM Key Metrics

Key financial metrics for COSM
Metric	Value
Price	$0.27
Market Cap	$15.37M
P/E Ratio	-0.45
EPS	$-0.63
Dividend Yield	0.00%
52-Week High	$1.32
52-Week Low	$0.28
Volume	220.24K
Avg Volume	0
Revenue (TTM)	$65.27M
Net Income	$-19.14M
Gross Margin	12.10%

Recent COSM Insider Trades

Siokas Grigorios bought 388.53K (~$145.00K) on Feb 12, 2026.
Siokas Grigorios bought 291.26K (~$120.00K) on Feb 11, 2026.
Siokas Grigorios bought 90.33K (~$45.00K) on Jan 23, 2026.
Siokas Grigorios bought 353.32K (~$175.00K) on Jan 20, 2026.
Siokas Grigorios bought 493.50K (~$220.00K) on Jan 14, 2026.

Latest COSM News

Cosmos Health Projects $3.2M U.S. Annual Revenue from Fort18 Launch — May 11, 2026
Cosmos Health Launches Fort18 After 5.1× Clinical Endurance Boost — May 6, 2026
Cosmos Health Forecasts Over $2.5M Annual Cur18 US Revenue Within 18 Months — Apr 30, 2026
Cosmos Health Launches 18 Series with Three Products Targeting $7.8B Market — Apr 21, 2026
Cosmos Health to Launch Liv18™ U.S. Production in April 2026 With $5M Revenue Forecast — Apr 20, 2026

COSM Analyst Consensus

COSM analyst coverage data. Average price target: $0.00.

Common questions about COSM

Who is trading COSM stock inside the company?: Recent COSM insider activity includes Siokas Grigorios bought 388.53K, Siokas Grigorios bought 291.26K, Siokas Grigorios bought 90.33K, Siokas Grigorios bought 353.32K, and Siokas Grigorios bought 493.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for COSM?: Yes. Rallies tracks COSM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is COSM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for COSM. It does not provide personalized investment advice.